Navicixizumab ELISA Kit
Product Specifications
Background
Navicixizumab is an anti-DLL4/VEGF bispecific antibody that has demonstrated robust in vivo antitumor efficacy in a number of solid tumor xenografts.
Specifications
Navicixizumab
Product Name Alternative
OMP-305B83, CAS: 1638338-43-8
Detection Method
Colorimetric
Assay Type
Quantitative
Sample Type
Plasma, Serum
Detection Range
0.31-5 μg/mL
Recovery
80-120%
Sensitivity
0.156 μg/ml
Shipping Conditions
2-8 °C
Storage Conditions
The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition.
Notes
For Research Use Only.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
